Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1135 |
|---|---|
| Identifier | NCT06049017 |
| Trial Title | A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: JNJ-77242113|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-10-09 |
|---|---|
| Primary Completion Date | 2024-09-26 |
| Completion Date | 2026-01-16 |